Search

everythinglearnresearchcommunity

for

Search:↓

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

New drug uses show promise but need more research.

The review lists substances from an ancient text that are good for hair health.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

The document summarized how various modern drugs are made.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Targeting the RAAS with small molecules can improve cardiovascular disease treatments.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Psychoactive drugs can help treat skin conditions linked to psychological issues.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Nardostachys jatamansi DC compounds help promote hair growth.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.